Tamer T Önder

10PUBLICATIONS
39CO-AUTHORS
Haematological tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz

|Mar 19, 2025
A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming.

Gülben Gürhan, Kenan Sevinç, Can Aztekin

|Feb 05, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer.

Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli

|Aug 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.

Ozlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen

Pageof 2